Corbus Pharmaceuticals Holdings (CRBP) Shares Outstanding (Diluted Average) (2018 - 2025)

Corbus Pharmaceuticals Holdings' Shares Outstanding (Diluted Average) history runs 8 years deep, the most recent figure standing at $12.3 million for Q3 2025.

• In Q3 2025, Shares Outstanding (Diluted Average) rose 2.44% year-over-year to $12.3 million; the TTM figure through Sep 2025 stood at $12.3 million (up 2.44% YoY), while the FY2024 annual figure was $10.9 million, up 152.23% from the prior year.
• Shares Outstanding (Diluted Average) was $12.3 million for Q3 2025 at Corbus Pharmaceuticals Holdings, up from $12.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $122.2 million in Q3 2021 to a low of $4.1 million in Q4 2021.
• Historically, Shares Outstanding (Diluted Average) has averaged $14.0 million across 5 years, with a median of $4.4 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Diluted Average) plunged 96.59% in 2022, then surged 171.6% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $4.1 million in 2021, then gained by 1.85% to $4.2 million in 2022, then gained by 3.76% to $4.3 million in 2023, then surged by 152.23% to $10.9 million in 2024, then increased by 12.75% to $12.3 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $12.3 million (Q3 2025), $12.2 million (Q2 2025), and $12.2 million (Q1 2025), per Business Quant data.